Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagen Cross-Linking (18 mW/cm2) for Keratoconus and Ectasia
NCT02762253Phase 2Terminated
- Sponsor
- NVISION Eye Centers
- Start
- Sep 2012
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of riboflavin in keratoconus, corneal ectasia, sponsored by NVISION Eye Centers. Started Sep 2012; status: terminated.
02
Drugs
riboflavin
03
Conditions
keratoconuscorneal ectasia
Beyond the preview
Go deeper on NCT02762253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02762253.